Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.
A stepped care approach seems beneficial for insomnia treatment among cancer survivors.
A study finds that in characterization of peripheral nerve sheath tumors as benign or malignant in patients with neurofibromatosis type 1, MRI-obtained apparent diffusion coefficient and FDG-PET/CT-obtained maximum standardized uptake values are excellent imaging markers.
The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
A comparison of AEDs finds that while most were not associated with skin cancer, carbamazepine and lamotrigine were associated with squamous cell carcinoma.
Researchers compared long-term memory trajectories in patients before and after they developed incident cancer to those of similarly aged individuals not diagnosed with cancer.
For older patients with blood cancers, gait speed can identify frailty and predict outcomes.
Highest incidence seen for patients with non-small cell lung cancer and triple-negative breast cancer
Clinicians should know that chemotherapy-induced cognitive impairment, chemobrain, chemofog, or whatever you want to call it is a real phenomenon.
For patients with melanoma and untreated brain metastases, nivolumab combined with ipilimumab shows clinically meaningful efficacy.
